MICROBIOLOGÍA, ENFERMEDADES INFECCIOSAS, ANTIMICROBIANOS Y TERAPIA GÉNICA
Institut Pasteur
París, FranciaPublicaciones en colaboración con investigadores/as de Institut Pasteur (6)
2020
-
Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane Environments
Cell Reports, Vol. 32, Núm. 7
2005
-
Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes
Journal of Clinical Microbiology, Vol. 43, Núm. 5, pp. 2492-2493
2004
-
An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae [1]
Journal of Antimicrobial Chemotherapy
2003
-
Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: A single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains
Journal of Clinical Microbiology, Vol. 41, Núm. 4, pp. 1574-1585
2002
-
TEM-103/IRT-28 β-lactamase, a new TEM variant produced by Escherichia coli BM4511
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 11, pp. 3627-3629
-
parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513 [3]
Antimicrobial Agents and Chemotherapy